Cargando…

Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group

To determine if the time-to-chemotherapy (TTC) after primary macroscopic complete cytoreductive surgery (CRS) influences recurrence-free survival (RFS) and overall survival (OS) in patients with epithelial ovarian cancer (EOC). We conducted an observational multicenter retrospective cohort analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rocher, Grégoire, Gaillard, Thomas, Uzan, Catherine, Collinet, Pierre, Bolze, Pierre-Adrien, Ballester, Marcos, Bendifallah, Sofiane, Ouldamer, Lobna, Touboul, Cyril, Huchon, Cyrille, Lavoue, Vincent, Dabi, Yohann, Akladios, Cherif, Coutant, Charles, Raimond, Emilie, Bricou, Alexandre, Canlorbe, Geoffroy, Azaïs, Henri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961531/ https://www.ncbi.nlm.nih.gov/pubmed/33806443 http://dx.doi.org/10.3390/jcm10051058

Ejemplares similares

Impact on Prognosis of the Surgical Route, Laparoscopy or Laparotomy, for the Surgical Staging of Early Stage Ovarian Cancer—A Study from the FRANCOGYN Group
por: Merlier, Margaux, et al.
Publicado: (2020)

Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF()
por: Akladios, Cherif, et al.
Publicado: (2020)

Therapeutic value of surgical paraaortic staging in locally advanced cervical cancer: a multicenter cohort analysis from the FRANCOGYN study group
por: Dabi, Yohann, et al.
Publicado: (2018)

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
por: Reboux, Pierre-Alain, et al.
Publicado: (2019)

Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group
por: Lecointre, Lise, et al.
Publicado: (2021)

Recurrence Pattern of Cervical Cancer Based on the Platinum Sensitivity Concept: A Multi-Institutional Study from the FRANCOGYN Group
por: de Foucher, Tiphaine, et al.
Publicado: (2020)

Ovarian Cancer in the Elderly: Time to Move towards a More Logical Approach to Improve Prognosis—A Study from the FRANCOGYN Group
por: Dion, Ludivine, et al.
Publicado: (2020)

Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN)
por: Bund, Virginie, et al.
Publicado: (2020)

Management and Survival of Elderly and Very Elderly Patients with Ovarian Cancer: An Age-Stratified Study of 1123 Women from the FRANCOGYN Group
por: Joueidi, Yolaine, et al.
Publicado: (2020)

Using a new diagnostic tool to predict lymph node metastasis in advanced epithelial ovarian cancer leads to simple lymphadenectomy decision rules: A multicentre study from the FRANCOGYN group
por: Mimoun, Camille, et al.
Publicado: (2021)

Prise en charge chirurgicale des cancers gynécologiques en période de pandémie COVID-19 – Recommandations du Groupe FRANCOGYN pour le CNGOF
por: Akladios, C., et al.
Publicado: (2020)

Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
por: Dabi, Yohann, et al.
Publicado: (2020)

Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer
por: Dabi, Yohann, et al.
Publicado: (2018)

Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group
por: Ouldamer, Lobna, et al.
Publicado: (2016)

Presentation and Prognosis of Primary Expansile and Infiltrative Mucinous Carcinomas of the Ovary
por: Huin, Marine, et al.
Publicado: (2022)

A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer
por: Métairie, Marie, et al.
Publicado: (2023)

Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group
por: Ozenne, Adele, et al.
Publicado: (2022)

Onco-gynecologic surgery in the COVID-19 era: Risks and precautions—A position paper from FRANCOGYN, SCGP, SFCO, and SFOG
por: Lavoué, Vincent, et al.
Publicado: (2020)

The impact of the COVID-19 coronavirus pandemic on the surgical management of gynecological cancers: Analysis of the multicenter database of the French SCGP and the FRANCOGYN group
por: Jouen, Théo, et al.
Publicado: (2021)

Microscopic Peritoneal Residual Disease after Complete Macroscopic Cytoreductive Surgery for Advanced High Grade Serous Ovarian Cancer
por: Azaïs, Henri, et al.
Publicado: (2020)

Results of a 2021 French National Survey on Management of Patients with Advanced Stage Epithelial Ovarian Cancer
por: Drouin, Leonor, et al.
Publicado: (2021)

Impact of the first lockdown for coronavirus 19 on breast cancer management in France: A multicentre survey
por: Murris, Floriane, et al.
Publicado: (2021)

The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis
por: Delangle, Romain, et al.
Publicado: (2019)

Residual Microscopic Peritoneal Metastases after Macroscopic Complete Cytoreductive Surgery for Advanced High-Grade Serous Ovarian Carcinoma: A Target for Folate Receptor Targeted Photodynamic Therapy?
por: Moinard, Morgane, et al.
Publicado: (2022)

Role of miRNAs in Normal Endometrium and in Endometrial Disorders: Comprehensive Review
por: Kolanska, Kamila, et al.
Publicado: (2021)

Total Hysterectomy by Low-Impact Laparoscopy to Decrease Opioids Consumption: A Prospective Cohort Study
por: Dabi, Yohann, et al.
Publicado: (2022)

Assessment of Lymph Node Involvement with PET-CT in Advanced Epithelial Ovarian Cancer. A FRANCOGYN Group Study
por: Tardieu, Antoine, et al.
Publicado: (2021)

Clues for Improving the Pathophysiology Knowledge for Endometriosis Using Serum Micro-RNA Expression
por: Dabi, Yohann, et al.
Publicado: (2022)

MicroRNome analysis generates a blood-based signature for endometriosis
por: Bendifallah, Sofiane, et al.
Publicado: (2022)

Overview of non-coding RNAs in breast cancers
por: Dabi, Yohann, et al.
Publicado: (2022)

A Bioinformatics Approach to MicroRNA-Sequencing Analysis Based on Human Saliva Samples of Patients with Endometriosis
por: Bendifallah, Sofiane, et al.
Publicado: (2022)

Just how accurate are the major risk stratification systems for early-stage endometrial cancer?
por: Bendifallah, S, et al.
Publicado: (2015)

Value of non-coding RNAs to assess lymph node status in cervical cancer
por: Dabi, Yohann, et al.
Publicado: (2023)

Machine learning algorithms as new screening approach for patients with endometriosis
por: Bendifallah, Sofiane, et al.
Publicado: (2022)

Insight on Non-Coding RNAs from Biofluids in Ovarian Tumors
por: Dabi, Yohann, et al.
Publicado: (2023)

Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer
por: de Foucher, Tiphaine, et al.
Publicado: (2018)

Associated Lichen Sclerosis Increases the Risk of Lymph Node Metastases of Vulvar Cancer
por: Dabi, Yohann, et al.
Publicado: (2020)

Multicenter External Validation of the Deep Pelvic Endometriosis Index Magnetic Resonance Imaging Score
por: Thomassin-Naggara, Isabelle, et al.
Publicado: (2023)

Robotic-assisted benign hysterectomy compared with laparoscopic, vaginal, and open surgery: a systematic review and meta-analysis
por: Lenfant, Louis, et al.
Publicado: (2023)

Salivary MicroRNA Signature for Diagnosis of Endometriosis
por: Bendifallah, Sofiane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bfcdhbrcv7qhplh1a2irodg5q4